Skip to main content
TipRanks
Go Ultimate75% OFF

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Financial Statements

7 Followers

GlaxoSmithKline Pharmaceuticals Limited Financial Overview

GlaxoSmithKline Pharmaceuticals Limited's market cap is currently ₹452.24B. The company's EPS TTM is ₹67.68; its P/E ratio is 39.38; and it has a dividend yield of 2.13%. GlaxoSmithKline Pharmaceuticals Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 38.22B₹ 37.26B₹ 34.42B₹ 32.26B₹ 32.64B
Gross Profit₹ 16.65B₹ 22.53B₹ 20.22B₹ 18.68B₹ 18.14B
Operating Income₹ 12.60B₹ 11.14B₹ 8.38B₹ 7.48B₹ 6.99B
EBITDA₹ 14.75B₹ 13.28B₹ 8.88B₹ 9.04B₹ 8.49B
Net Income₹ 10.36B₹ 9.28B₹ 5.90B₹ 6.11B₹ 16.95B
Balance Sheet
Cash & Short-Term Investments₹ 27.56B₹ 24.98B₹ 18.57B₹ 16.54B₹ 29.03B
Total Assets₹ 43.24B₹ 41.08B₹ 35.57B₹ 33.27B₹ 46.33B
Total Debt₹ 332.70M₹ 99.50M₹ 186.65M₹ 155.40M₹ 200.76M
Net Debt₹ -10.69B₹ -13.94B₹ -455.06M₹ -194.00M₹ -2.66B
Total Liabilities₹ 20.56B₹ 21.57B₹ 17.79B₹ 15.85B₹ 19.70B
Stockholders' Equity₹ 22.67B₹ 19.51B₹ 17.78B₹ 17.41B₹ 26.63B
Cash Flow
Free Cash Flow₹ 9.67B₹ 12.67B₹ 5.51B₹ 4.40B₹ 7.76B
Operating Cash Flow₹ 10.22B₹ 12.90B₹ 5.82B₹ 4.84B₹ 8.11B
Investing Cash Flow₹ 2.78B₹ -458.10M₹ 87.12M₹ 8.08B₹ -4.06B
Financing Cash Flow₹ -7.37B₹ -7.69B₹ -5.61B₹ -15.43B₹ -5.24B

Currency in INR

GlaxoSmithKline Pharmaceuticals Limited Earnings and Revenue History

015B30B45B0 %20 %40 %60 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin

GlaxoSmithKline Pharmaceuticals Limited Liabilities to Assets

020B40B60B32 %40 %48 %56 %LiabilitiesLiabilities to Assets2017201820192020202120222023202420252026AssetsLiabilitiesLiabilities to Assets

GlaxoSmithKline Pharmaceuticals Limited Cash Flow

-20B-15B-10B-5B05B10B15B2017201820192020202120222023202420252026OperatingInvestingFinancing

GlaxoSmithKline Pharmaceuticals Limited Forecast EPS vs Actual EPS

121416182022Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27EPS EstimateBeatMiss